Stellar (XLM) shows signs of recovery with key technical indicators suggesting a rally. XLM could break through resistance ...
The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...
Spinal muscular atrophy (SMA) is a debilitating genetic condition that’s usually fatal by a few years of age. But an ...
Researchers at the University of Pittsburgh say a new minimally invasive intervention can target the root cause of neural function loss.
More changes are coming to SEPTA. After beginning its rollout in 2024, SEPTA Metro will officially launch on Sunday, February ...